Back to Results
First PageMeta Content
Porphyrias / Afamelanotide / Medical statistics / Clinical research / Pharmacology / Erythropoietic protoporphyria / Actinic keratosis / Urticaria / Squamous-cell carcinoma / Medicine / Health / Peptide hormones


Document Date: 2012-04-19 14:38:18

Open Document

File Size: 52,82 KB

Share Result on Facebook

City

San Francisco / Melbourne / Zürich / /

Company

EPP Clinuvel Pharmaceuticals Limited / Clinuvel Pharmaceuticals Limited / Colin Mackie Clinuvel Pharmaceuticals / /

Continent

Australia / Europe / /

Country

Australia / /

/

Event

FDA Phase / /

IndustryTerm

biopharmaceutical / cancer treatment / treatment protocol / pharmaceutical / /

MedicalCondition

Squamous Cell Carcinoma / cancer / disease / severe phototoxicity / phototoxicity / pain / Porphyrias / erythropoietic porphyrias / erythropoietic protoporphyria / deficiency / rare genetic and metabolic disease / disorders / /

MedicalTreatment

treatment protocol / Photodynamic Therapy / Organ Transplant / radiation / /

Organization

FDA / /

Person

Helmer Agersborg / Philippe Wolgen / /

/

Position

CEO / /

Product

CUV017 / UR9 / CUV0017 / /

ProvinceOrState

Victoria / /

Technology

radiation / same treatment protocol / /

URL

www.clinuvel.com / /

SocialTag